Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Objective. Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Ital...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Specchia, Maria Lucia, de Waure, Chiara, Gualano, Maria Rosaria, Doria, Andrea, Turchetti, Giuseppe, Pippo, Lara, Di Nardo, Francesco, Capizzi, Silvio, Cadeddu, Chiara, Kheiraoui, Flavia, Iaccarino, Luca, Pierotti, Francesca, Palla, Ilaria, Veneziano, Maria Assunta, Gliubizzi, Daniela, Sferrazza, Antonella, Nicolotti, Nicola, Porcasi, Rolando, La Torre, Giuseppe, Di Pietro, Maria Luisa, Ricciardi, Walter
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150460/
https://ncbi.nlm.nih.gov/pubmed/25243173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/704207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados